Literature DB >> 1900646

Cerebrovascular CO2 reactivity during delayed vasospasm in a canine model of subarachnoid hemorrhage.

M N Diringer1, D S Heffez, L Monsein, J R Kirsch, D F Hanley, R J Traystman.   

Abstract

While the in vitro reactivity of cerebral conducting vessels following subarachnoid hemorrhage has been extensively studied, in vivo cerebrovascular CO2 reactivity has not been systematically investigated. We tested the hypothesis that, in the canine model of subarachnoid hemorrhage, the rise in cerebral blood flow normally seen with hypercapnia is blunted during delayed vasospasm. Four groups of animals were studied: one received two 4-ml subarachnoid injections of nonheparinized arterial blood into the cisterna magna (n = 8), one received three subarachnoid injections of 5 ml blood (n = 5), one received two subarachnoid injections of 4 ml saline (n = 5), and a control group (n = 5) had no subarachnoid injections or angiography. Basilar artery diameter was measured from baseline and follow-up angiography. We determined CO2 reactivity by randomly varying the concentration of inspired CO2 and measuring regional cerebral blood flow with radiolabeled microspheres. Basilar artery diameter was not affected by saline injection and was reduced by 26 +/- 2.9% in the two-hemorrhage group and 55 +/- 1.9% in the three-hemorrhage group. Baseline cerebral blood flow and CO2 reactivity were similar in all four groups. We conclude that, in this model of delayed vasospasm, regional cerebral vascular CO2 reactivity is intact and extrapolation of in vitro data regarding basilar artery diameter and reactivity to cerebral blood flow must be done cautiously.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1900646     DOI: 10.1161/01.str.22.3.367

Source DB:  PubMed          Journal:  Stroke        ISSN: 0039-2499            Impact factor:   7.914


  7 in total

1.  CO2 has no therapeutic effect on early microvasospasm after experimental subarachnoid hemorrhage.

Authors:  Benjamin Friedrich; Radoslaw Michalik; Anna Oniszczuk; Khalid Abubaker; Ewa Kozniewska; Nikolaus Plesnila
Journal:  J Cereb Blood Flow Metab       Date:  2014-05-28       Impact factor: 6.200

2.  Neuronal and astrocytic apoptosis after subarachnoid hemorrhage: a possible cause for poor prognosis.

Authors:  Mohammed Sabri; Ayako Kawashima; Jinglu Ai; R Loch Macdonald
Journal:  Brain Res       Date:  2008-08-23       Impact factor: 3.252

3.  Controversy: does prevention of vasospasm in subarachnoid hemorrhage improve clinical outcome?

Authors:  Michael N Diringer
Journal:  Stroke       Date:  2013-06       Impact factor: 7.914

4.  Therapeutic hypercapnia for prevention of secondary ischemia after severe subarachnoid hemorrhage: physiological responses to continuous hypercapnia.

Authors:  Christian Stetter; Franziska Weidner; Nadine Lilla; Judith Weiland; Ekkehard Kunze; Ralf-Ingo Ernestus; Ralf Michael Muellenbach; Thomas Westermaier
Journal:  Sci Rep       Date:  2021-06-03       Impact factor: 4.379

Review 5.  Neurological and neurobehavioral assessment of experimental subarachnoid hemorrhage.

Authors:  Hyojin Jeon; Jinglu Ai; Mohamed Sabri; Asma Tariq; Xueyuan Shang; Gang Chen; R Loch Macdonald
Journal:  BMC Neurosci       Date:  2009-08-25       Impact factor: 3.288

6.  Delayed Cerebral Ischemia After Subarachnoid Hemorrhage: Experimental-Clinical Disconnect and the Unmet Need.

Authors:  Fumiaki Oka; David Y Chung; Michiyasu Suzuki; Cenk Ayata
Journal:  Neurocrit Care       Date:  2020-02       Impact factor: 3.210

Review 7.  To look beyond vasospasm in aneurysmal subarachnoid haemorrhage.

Authors:  Giulia Cossu; Mahmoud Messerer; Mauro Oddo; Roy Thomas Daniel
Journal:  Biomed Res Int       Date:  2014-05-19       Impact factor: 3.411

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.